Date: {{$ActivityAssignDate}}

Dear Dr. {{$doctorName}},


Subject: Cross sectional survey to assess disease perceptive and management practices of chronic constipation in Indian physicians


Chronic constipation is a common complaint in any population. Constipation is basically a patient's perception variously described as subjective feeling of inability to pass feces smoothly or regularly, hard stool or obstruction to its passage, unproductive urges or feeling of incomplete evacuation. Risk factors for constipation include older age, physical inactivity, low caloric intake, low-fiber diet, low income, low educational level, various systemic and gastrointestinal (GI) disorders as well as medications.


Chronic constipation (CC) is a common presenting problem among women and older individuals that causes worsening of patients' quality of life (QoL) and consumes extensive healthcare resources. In spite of the scarcity of data in India, published literature indicates CC to be a common health problem in India, with a population prevalence ranging from 2.6% to 24.8%. Patients with chronic constipation also have co-morbidities like Diabetes, Cardiovascular diseases, chronic kidney diseases etc.


It has been evident that the health burden related to CC has been comparable to other prevalent serious conditions like hypertension and type 2 diabetes mellitus. The vast majority of patients with CC are treated with non-operative methods that include lifestyle modification, pharmacotherapy and biofeedback therapy. With the publication of the latest Rome IV criteria, investigative and therapeutic approaches toward management of CC from an Indian perspective are of growing interest to clinicians.


However, there is limited data available on constipation disease perspective, associated comorbidities and its management practices. Therefore, this cross-sectional study is designed to understand the disease perspective and management of chronic constipation.


If you agree to participate, you will need to provide assessment response, on to the standard data collection form (which we call DCF). A monitor will assist you in verifying and collecting the DCF


We trust you and we are partners in promoting safe and effective drug therapy. In that spirit we hope you will consent to participate in this study. If you do, please sign and return the enclosed reply along with your visiting card for accuracy of records.



Yours truly,

Sun Pharmaceutical Laboratories Limited